Management of erectile dysfunction and LUTS/incontinence: the two most common, long-term side effects of prostate cancer treatment.

Management of erectile dysfunction and LUTS/incontinence: the two most common, long-term side effects of prostate cancer treatment. Can J Urol. 2020 Feb;27(1S1):17-24 Authors: Shabataev V, Saadat SH, Elterman DS Abstract The two major long-term concerns associated with different options for the management of prostate cancer, (including surgery, radiotherapy, brachytherapy, cryotherapy, HIFU, etc.) include difficulties with lower urinary tract symptoms (LUTS) and/or erectile dysfunction. LUTS can be in the form of stress urinary incontinence (SUI), urge urinary incontinence (UUI), frequency/urgency, and/or voiding difficulties. While surgery is mostly associated with SUI and radiation mostly results in UUI, there can be an overlap. Incontinence rates after cryotherapy and high intensity focused ultrasound (HIFU) are generally very low. Voiding difficulties can also happen after the above-mentioned options. Treatment of SUI can start with pelvic floor muscle exercises (PFME), penile clamps or urethral plugs. If these fail to provide satisfactory results the surgical options could include: urethral bulking agents, male slings, and artificial urinary sphincter (AUS). Surgical options are usually not recommended during the first 6-12 months after radical prostatectomy. Management of frequency, urgency and/or UUI can also be started with lifestyle modifications and PFME. Oral agents (anticholinergics and β3-agonists) are also considered before proceeding t...
Source: Canadian Journal of Urology - Category: Urology & Nephrology Tags: Can J Urol Source Type: research

Related Links:

I am a Canadian student, I am finishing my biology degree this year and I have unfortunately not been accepted into any schools so far (Applied to 9, 3 haven't replied yet but I am assuming they've denied me). I wasn't even able to get an interview... I have pretty standard/below average extracurriculars, nothing too special, my GPA is about 3.25~ and for the DAT I took it twice with the second attempt landing me AA: 19 TS: 19 with a shocking 15 in PAT. Canadian schools are too competitive... Looking for some advice regarding what I should do after being rejected
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pre-Dental Source Type: forums
Foods high in soluble fiber like oatmeal, nuts and beans were associated with reduced breast cancer incidence.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Breast Cancer Diet and Nutrition Fiber (Dietary) Source Type: news
Publication date: Available online 4 April 2020Source: Journal of Pharmaceutical and Biomedical AnalysisAuthor(s): Kaili Wang, Weijie Zhang, Zihan Wang, Ming Gao, Xinying Wang, Wenchao Han, Nan Zhang, Xia Xu
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 5 April 2020Source: Seminars in Cancer BiologyAuthor(s): Emad A. Rakha, Fresia G. Pareja
Source: Seminars in Cancer Biology - Category: Cancer & Oncology Source Type: research
Publication date: Available online 4 April 2020Source: Seminars in Cancer BiologyAuthor(s): Michela Biancolella, Barbara Testa, Leila Baghernajad Salehi, Maria Rosaria D’Apice, Giuseppe Novelli
Source: Seminars in Cancer Biology - Category: Cancer & Oncology Source Type: research
Publication date: Available online 4 April 2020Source: Seminars in Cancer BiologyAuthor(s): Jyoti Gupta, Haaris Ahsan Safdari, Mehboob Hoque
Source: Seminars in Cancer Biology - Category: Cancer & Oncology Source Type: research
CONCLUSION: Here, we present what, to the best of our knowledge, is the first reported case in which durvarumab resistance after definitive chemoradiotherapy in a patient with stage III pulmonary sarcomatoid carcinoma was overcome by pembrolizumab. PMID: 32245391 [PubMed - as supplied by publisher]
Source: BMC Pharmacology and Toxicology - Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Publication date: Available online 5 April 2020Source: Innovative Food Science &Emerging TechnologiesAuthor(s): Abdullateef Taiye Mustapha, Cunshan Zhou, Robert Amanor-Atiemoh, Tahany A.A. Ali, Hafida Wahia, Haile Ma, Yanhui Sun
Source: Innovative Food Science and Emerging Technologies - Category: Food Science Source Type: research
Publication date: Available online 4 April 2020Source: Food ChemistryAuthor(s): Luthando Nyaba, Philiswa N. Nomngongo
Source: Food Chemistry - Category: Food Science Source Type: research
More News: Botox | Brachytherapy | Brain | Canada Health | Cancer | Cancer & Oncology | Cryotherapy | Erectile Dysfunction | High Intensity Focused Ultrasound Therapy | Incontinence | Men | Neurology | Neurosurgery | Oral Cancer | Penile Cancer | Prostate Cancer | Prostatectomy | Ultrasound | Urology & Nephrology